|
|
|
Volumn 294, Issue 5550, 2001, Pages 2268-2269
|
|
Panel reviews risks of germ line changes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA;
GENE PRODUCT;
RECOMBINANT DNA;
VIRUS DNA;
CLINICAL RESEARCH;
DNA VECTOR;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
GERM LINE;
HEALTH CARE ORGANIZATION;
HEMOPHILIA B;
HUMAN;
NOTE;
PRIORITY JOURNAL;
SPERM;
UNITED STATES;
ADENO ASSOCIATED VIRUS;
ADVISORY COMMITTEE;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
GENETICS;
GENETICS AND REPRODUCTION;
ISOLATION AND PURIFICATION;
MALE;
RECOMBINANT DNA ADVISORY COMMITTEE;
SPERMATOZOON;
VIROLOGY;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
RECOMBINANT DNA ADVISORY COMMITTEE;
ADVISORY COMMITTEES;
CLINICAL TRIALS;
DEPENDOVIRUS;
DNA, RECOMBINANT;
DNA, VIRAL;
GENE THERAPY;
GENETIC VECTORS;
HEMOPHILIA B;
HUMAN;
MALE;
SEMEN;
SPERMATOZOA;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0035861722
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (20)
|
|
References (0)
|